Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Line Insertion Site”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Very early researchNot Yet RecruitingNCT07458919
What this trial is testing

Therapy for Advanced NSCLC With EGFR 19delins Mutation

Who this might be right for
Lung Cancer
Fuzhou General Hospital 94
Large-scale testing (Phase 3)Active Not RecruitingNCT05607550
What this trial is testing

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

Who this might be right for
Metastatic Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung CancerEGFR Exon 20 Mutations
ArriVent BioPharma, Inc. 398
Large-scale testing (Phase 3)Active Not RecruitingNCT05668988
What this trial is testing

DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)

Who this might be right for
Non-small Cell Lung Cancer
Dizal Pharmaceuticals 324
Large-scale testing (Phase 3)Active Not RecruitingNCT04129502
What this trial is testing

TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Takeda 354
Not applicableStudy completedNCT02929368
What this trial is testing

SHERLOCK 3CG vs. Fluoroscopy in Implantation of PICC-Line

Who this might be right for
Patients With PICC-Line
Jena University Hospital 210
Not applicableActive Not RecruitingNCT06451185
What this trial is testing

Statseal® for Central Venous Catheter Insertion Sites in Critical Care

Who this might be right for
Central LineCentral Venous CatheterVascular Access+2 more
Liverpool Heart and Chest Hospital NHS Foundation Trust 450
Not applicableStudy completedNCT01402778
What this trial is testing

Fixation of Thoracic Epidurals Influencing Catheter-related Infections and Dislocation

Who this might be right for
DislocationInfectionLine Colonisation+1 more
Heinrich-Heine University, Duesseldorf 140
Not applicableStudy completedNCT05187143
What this trial is testing

Results of a New Fully Tapered Implant at One Year

Who this might be right for
Implant Site Reaction
University of Santiago de Compostela 30
Not applicableLooking for participantsNCT07506005
What this trial is testing

Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line

Who this might be right for
Colorectal CancerDiverticulitis
Kepler University Hospital 102
Not applicableStudy completedNCT06057363
What this trial is testing

Volumetric Evaluation of Gingival Augmentation Around Dental Implants

Who this might be right for
Atrophy of Gingiva
Odontostomatologic Laser Therapy Center, Florence, Italy 12
Not applicableWithdrawnNCT03282292
What this trial is testing

Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery

Who this might be right for
Central Line-associated Bloodstream Infection (CLABSI)Central Venous Catheter Associated Bloodstream InfectionHeart; Surgery, Heart, Functional Disturbance as Result+2 more
IRCCS Policlinico S. Donato
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944772
What this trial is testing

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 247
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06514027
What this trial is testing

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

Who this might be right for
Non Small Cell Lung Cancer
BeBetter Med Inc 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT05767892
What this trial is testing

YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Suzhou Puhe Pharmaceutical Technology Co., LTD 350
Not applicableStudy completedNCT04432519
What this trial is testing

Multi-level Dimensional Changes at Immediate Implant Sites

Who this might be right for
Dental Implant Failed
Universidade Católica Portuguesa 28
Testing effectiveness (Phase 2)UnknownNCT02095743
What this trial is testing

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer

Who this might be right for
Early Stage Breast Carcinoma
Centre Henri Becquerel 256
Not applicableUnknownNCT01893060
What this trial is testing

Umbilical Cord Care for the Prevention of Colonization

Who this might be right for
Line Insertion SiteCentral Line-associated Bloodstream Infection (CLABSI)
University of Virginia 100